New Zealand markets close in 3 hours 13 minutes
  • NZX 50

    11,365.67
    -11.45 (-0.10%)
     
  • NZD/USD

    0.5967
    0.0000 (-0.00%)
     
  • NZD/EUR

    0.5635
    +0.0006 (+0.11%)
     
  • ALL ORDS

    7,249.50
    -29.10 (-0.40%)
     
  • ASX 200

    7,044.50
    -32.00 (-0.45%)
     
  • OIL

    89.66
    -0.02 (-0.02%)
     
  • GOLD

    1,933.60
    -3.00 (-0.15%)
     
  • NASDAQ

    14,768.90
    +67.80 (+0.46%)
     
  • FTSE

    7,623.99
    -59.92 (-0.78%)
     
  • Dow Jones

    34,006.88
    +43.04 (+0.13%)
     
  • DAX

    15,405.49
    -151.80 (-0.98%)
     
  • Hang Seng

    17,729.29
    -328.16 (-1.82%)
     
  • NIKKEI 225

    32,442.91
    -235.71 (-0.72%)
     
  • NZD/JPY

    88.7240
    -0.0470 (-0.05%)
     

Why Intercept Pharmaceuticals Stock Plunged Today

Why Intercept Pharmaceuticals Stock Plunged Today

Shares of the non-viral liver disease specialist Intercept Pharmaceuticals (NASDAQ: ICPT) are under heavy pressure today. The big loss came in response to weaker-than-expected 2023 first-quarter sales of Intercept's primary biliary cholangitis (PBC) therapy, Ocaliva (obeticholic acid). This relatively modest revenue miss probably isn't the reason Intercept's shares are falling today.